Incyte
INCY
#1136
Rank
C$28.19 B
Marketcap
C$143.64
Share price
-2.73%
Change (1 day)
38.19%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): C$8.54

According to Incyte's latest financial reports the company's current EPS (TTM) is C$8.50. In 2024 the company made an earnings per share (EPS) of C$0.43 a decrease over its 2023 EPS that were of C$3.71.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$8.541883.09%
2024C$0.43-88.39%
2023C$3.7173.38%
2022C$2.14-64.1%
2021C$5.96-408.63%
2020C-$1.93-166.83%
2019C$2.89300%
2018C$0.72-133.33%
2017C-$2.17-378.57%
2016C$0.782700%
2015C$0.02777-106.67%
2014C-$0.42-44.44%
2013C-$0.7550%
2012C-$0.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$18.10 112.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.32-60.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$28.49 235.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.39-71.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.17-101.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C-$0.32-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.22 20.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
C-$1.17-113.73%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C-$0.81-109.48%๐Ÿ‡บ๐Ÿ‡ธ USA